237 related articles for article (PubMed ID: 36982551)
1. Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review.
Padežnik T; Oleksy A; Cokan A; Takač I; Sobočan M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982551
[TBL] [Abstract][Full Text] [Related]
2. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
3. HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
Cardeal LB; Boccardo E; Termini L; Rabachini T; Andreoli MA; di Loreto C; Longatto Filho A; Villa LL; Maria-Engler SS
PLoS One; 2012; 7(3):e33585. PubMed ID: 22438955
[TBL] [Abstract][Full Text] [Related]
4. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
5. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study].
Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T
Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
8. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis.
Sillem M; Prifti S; Koch A; Neher M; Jauckus J; Runnebaum B
Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):167-74. PubMed ID: 11301163
[TBL] [Abstract][Full Text] [Related]
9. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp.
Inagaki N; Ung L; Otani T; Wilkinson D; Lopata A
Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):197-203. PubMed ID: 14597251
[TBL] [Abstract][Full Text] [Related]
10. Uterine cervical carcinoma: role of matrix metalloproteinases (review).
Libra M; Scalisi A; Vella N; Clementi S; Sorio R; Stivala F; Spandidos DA; Mazzarino C
Int J Oncol; 2009 Apr; 34(4):897-903. PubMed ID: 19287946
[TBL] [Abstract][Full Text] [Related]
11. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-induced cervical extracellular matrix remodelling in pregnancy and cervical cancer.
Amabebe E; Ogidi H; Anumba DO
Reprod Fertil; 2022 Jul; 3(3):R177-R191. PubMed ID: 37931406
[TBL] [Abstract][Full Text] [Related]
14. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix.
Argüello-Ramírez J; Pérez-Cárdenas E; Delgado-Chávez R; Solorza-Luna G; Villa-Treviño S; Arenas-Huertero F
Int J Gynecol Cancer; 2004; 14(2):333-40. PubMed ID: 15086734
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.
Jedryka M; Chrobak A; Chelmonska-Soyta A; Gawron D; Halbersztadt A; Wojnar A; Kornafel J
Int J Gynecol Cancer; 2012 Oct; 22(8):1303-9. PubMed ID: 22964525
[TBL] [Abstract][Full Text] [Related]
17. HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.
Kaewprag J; Umnajvijit W; Ngamkham J; Ponglikitmongkol M
PLoS One; 2013; 8(8):e71611. PubMed ID: 23967226
[TBL] [Abstract][Full Text] [Related]
18. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
19. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
